Alliance for Multispecialty Research   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Knoxville TN United States (2017)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (6)

Key: Alliance for Multispecialty Research (0) Acquired (6)

bifidobacterium bifidum (1 trial)

chickpea (1 trial)

diclofenac (voltaren) (3 trials)

influenza vaccine, recombinant hemagglutinin (1 trial)

lactobacillus delbrueckii (2 trials)

meloxicam (mobic) (1 trial)

Drugs in Phase 2 Trials (9)

Key: Alliance for Multispecialty Research (0) Acquired (9)

as03 (1 trial)

desflurane (suprane) (1 trial)

favipiravir (1 trial)

inactivated influenza vaccine (1 trial)

influenza vlp vaccine (1 trial)

nb-001 (1 trial)

panblok (1 trial)

peramivir (rapivab) (1 trial)

sitagliptin (januvia) (1 trial)

Drugs in Phase 1 Trials (7)

Key: Alliance for Multispecialty Research (0) Acquired (7)

avi-6002 (1 trial)

crv 101 (1 trial)

eravacycline (Xerava) (1 trial)

itraconazole (sporanox) (1 trial)

medi7510 (1 trial)

prucalopride (1 trial)

vasomera (1 trial)

Drugs in Other Trials (2)

Key: Alliance for Multispecialty Research (0) Acquired (2)

sodium bicarbonate (1 trial)

thylate (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 21
  • # of Trial APIs: 24